Clinical trial
Identifying Genetic Markers That Predict Microvolt T-wave Alternans Status and Arrhythmia Risk in Patients With Ischemic Heart Disease
NCT00583297 is registered in ClinicalTrials.gov with CardioDx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Genetic Markers That Predict Microvolt T-wave Alternans Status and Arrhythmia Risk in Patients With Ischemic Heart Disease
- Lead sponsor
- CardioDx
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- December 31, 2009
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrythmia, cardiovascular diseases, cvd, ventricular tachycardia